Florian Fuchs is an expert on advanced cellular models and early drug discovery.

Trained as a chemist, he quickly got interested in biological models and assay evaluations. Having received his PhD from the Ludwig-Maximilians-University at Munich and educated himself on Genome-wide siRNA perturbations and implementation of High Content Screening at the German Cancer Research Center at Heidelberg, he joined the Novartis Biomedical Research Institutes at Novartis Basel in 2010. There, he started as a lab head in cell-based assays and was holding a group leader position on cell-based screening and advanced cellular models. In 2021 he moved to Berlin to work as a lab head within the Lead Discovery Screening Department of the Nuvisan Innovation Campus Berlin.

In February 2022, he joined HeartBeat.bio as Chief Technology Officer.

„My deep understanding of pharma-based screening and emerging technologies, organ–on–a–chip applications and interest in tiny self-organizing three-dimensional structures called organoids, focus my interest on HeartBeat.bio. The application and feasibility of organoid technologies fordrug discovery are just about emerging and I hope to contribute to the mitigation of challenges and translate this technology into real-life pre-clinical applications.“